A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Popular GLP-1 weight loss drugs like Ozempic and Zepbound may help lower a woman’s risk for 14 types of cancer, a new study ...

Sleep apnea may lead to weight gain by disrupting sleep, affecting hunger hormones, slowing metabolism, and more. Lifestyle ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

and high-molecular-weight adiponectin) were strongly associated with indicators of obesity (elevated weight, body mass index [BMI], waist circumference, and body fat percentage). After adjustment ...

This Obesity Medicine Association (OMA ... increased leptin, decreased adiponectin, increased renin-angiotensin-aldosterone system activation, increased 11 beta-hydroxysteroid dehydrogenase ...

Obesity can: Lower SHBG (sex hormone-binding globulin), a protein that helps balance estrogen Raise leptin, a hormone that controls appetite and metabolism Lower adiponectin, a hormone that ...

After BMI adjustment, adiponectin remained protective, and leptin’s effects were limited. Among 4455 metabolically healthy participants, 71% remained healthy, whereas 29% transitioned to unhealthy.

Adiponectin and leptin levels were assessed at Visit 2, and their relationships with metabolic health transitions over six years were evaluated. Secondary analysis was conducted, splitting results by ...